Results 251 to 260 of about 433,780 (323)

Effect of butorphanol in combination with xylazine during castration of calves: A randomised trial under field conditions

open access: yesVeterinary Record, EarlyView.
Abstract Background In horses, cats and dogs, the opioid butorphanol has been proven effective in management of visceral pain and for peri‐ and postoperative pain relief. The aim of this study was to evaluate physiological responses and indicators of noxious stimuli when adding butorphanol to xylazine for sedation of bull calves during surgical ...
Axel Sannö   +3 more
wiley   +1 more source

Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer. [PDF]

open access: yesSci Rep
Westerberg M   +6 more
europepmc   +1 more source

Prevalence of hip and elbow dysplasia in young adult dogs in Sweden

open access: yesVeterinary Record, EarlyView.
Abstract Background Hip and elbow dysplasia (HD and ED) are common developmental orthopaedic disorders in dogs. The study objectives were to report population‐based estimates of HD and ED prevalence at screening in young adult dogs of different breeds and to evaluate the phenotypic association between HD and ED.
Karolina Engdahl   +6 more
wiley   +1 more source

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

open access: yes
Rheumatology &Autoimmunity, EarlyView.
Lilian Vasaitis   +5 more
wiley   +1 more source

In situ monitoring of cell adhesion kinetics using label‐free optical biosensors: Evaluating anticancer potential and selectivity of natural compounds

open access: yesVIEW, EarlyView.
The limitations of conventional techniques hinder the identification of natural compounds with anticancer potential in terms of speed, throughput, sensitivity, and capability of continuous monitoring of relevant biological effects. Novel label‐free optical biosensors represent new opportunities in the discovery of drug candidates, eliminating these ...
Beatrix Péter   +10 more
wiley   +1 more source

SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications. [PDF]

open access: yesDiabetes Obes Metab
Eriksson JW   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy